Review
doi: 10.1007/s001980070007.
Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs
Affiliations
- PMID: 11193241
- DOI: 10.1007/s001980070007
Item in Clipboard
Review
Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs
Osteoporos Int.
2000.
No abstract available
Similar articles
-
The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.Osteoporos Int. 2000;11 Suppl 6:S2-17. doi: 10.1007/s001980070002. Osteoporos Int. 2000. PMID: 11193237 Review. No abstract available.
-
Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.Spine J. 2018 Oct;18(10):1877-1887. doi: 10.1016/j.spinee.2018.05.020. Epub 2018 May 21. Spine J. 2018. PMID: 29793000
-
Biochemical bone markers.CAP Today. 1999 May;13(5):70-2, 74-8, 78-9. CAP Today. 1999. PMID: 10558046 No abstract available.
-
Efficacy of combined treatment with raloxifene and alfacalcidol on bone density and biochemical markers of bone turnover in postmenopausal osteoporosis.Endocr J. 2008 Mar;55(1):127-34. doi: 10.1507/endocrj.k07e-027. Epub 2008 Jan 24. Endocr J. 2008. PMID: 18219181 Clinical Trial.
-
Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.Endocr Regul. 2003 Dec;37(4):225-38. Endocr Regul. 2003. PMID: 15106819 Review.
Cited by
-
The Effect of a Moderate Exercise Program on Serum Markers of Bone Metabolism in Dogs.Animals (Basel). 2020 Aug 23;10(9):1481. doi: 10.3390/ani10091481. Animals (Basel). 2020. PMID: 32842472 Free PMC article.
-
Effect of Nasal Calcitonin on the Health-Related Quality of Life in Postmenopause Women Affected With Low Bone Density.Iran Red Crescent Med J. 2015 Jul 31;17(7):e6613. doi: 10.5812/ircmj.17(5)2015.6613. eCollection 2015 Jul. Iran Red Crescent Med J. 2015. PMID: 26421180 Free PMC article.
-
Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis.Osteoporos Int. 2008 Jan;19(1):87-94. doi: 10.1007/s00198-007-0485-y. Epub 2007 Oct 16. Osteoporos Int. 2008. PMID: 17938984 Clinical Trial.
-
Should the treatment of osteoporosis be more selective?Osteoporos Int. 2003 Apr;14(2):99-102. doi: 10.1007/s00198-002-1366-z. Epub 2003 Mar 12. Osteoporos Int. 2003. PMID: 12730748 Review. No abstract available.
-
A semimechanistic and mechanistic population PK-PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis.Br J Clin Pharmacol. 2004 Dec;58(6):618-31. doi: 10.1111/j.1365-2125.2004.02224.x. Br J Clin Pharmacol. 2004. PMID: 15563360 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
